Bay 11-7082 is an experimental drug which acts as an inhibitor of the NFκB pathway and the NLRP3 inflammasome. It has antiinflammatory effects and has potential applications in the treatment of conditions such as dermatitis, COVID-19, irritable bowel syndrome and certain forms of cancer.
See also NP3-146 YQ128
References